Progenra - The Ubiquitin Company

Home | Contact Us

The path to discovery starts here…

Progenra is committed exclusively to drug discovery in the
ubiquitin and ubiquitin-like protein pathways

Through our advanced platform for high-throughput screening against novel drug targets in these pathways, we are developing lead compounds to treat a variety of illnesses, including cancer, muscle wasting, and neurodegenerative disease.  We offer collaborative opportunities built around our novel screening technologies and our lead compounds.

Progenra News

Progenra announces the publication of a review highlighting deubiquitinases as novel anticancer targets.

More information...

Recent Publications

Recent publications from the R&D team covering Progenra's screening platforms and basic research on the ubiquitin pathway.

More information...

web design by JOT Infomedia